Verona Pharma plc (NASDAQ: VRNA) disclosed that it is planning to report its financial results for the three months completed March 31, 2021, on Thursday, April 29, 2021. The firm will host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to talk about these financial results and share a corporate update.
Shares of Verona Pharma plc (NASDAQ: VRNA) were plunged 2.07% at the time of writing on Wednesday. Verona Pharma plc (NASDAQ: VRNA) share price went from a low point around $3.70 to briefly over $15.71 in the past 52 weeks, though shares have since pulled back to $7.58. VRNA's market cap has remained high, reaching $405.53M at the time of writing.
Looking at its profitability, it has a Return on Assets (ROA) of -48.48% and Return on Equity (ROE) of -60.90%. Turing our focus on its liquidity, it has a current ratio of 14.30 and a quick ratio of 14.30. Verona Pharma has a total market capitalization of $405.53 million at the time of writing.
About Verona Pharma
Verona Pharma has gained recognition as a clinical-stage biopharmaceutical firm engaged in expanding and commercializing groundbreaking therapies for the cure of respiratory diseases with substantial unsatisfied medical requirements.